Buying of ‘No Trademark / Brand’ Soy Sauce may result to cancer:

12:26:00 AM

3-Monochloropropane-1.2-diol (3-MCPD) is a by-product of soy sauce
 manufacturing which utilizes hydrolyzed vegetable protein (HVP) as a component. In the 1990s study proved that 3-MCPD can be a source of cancer in animals and continuing studies provide as a basis for setting tolerable restrictions in food products that are far under the experiential levels creating cancer, in 2002 the Philippines BFAD accepted as a standard 1ppm as the maximum allowable limit; this is the same standard used by the US FDA. All registered imported products and local products have since then conformed to these prerequisite.  Actually, the levels among recorded products are way below this limit. Based on Tolerable Daily Intake (TDI) of 2 micrograms per kilogram per day which is an estimation of safety, a person who is consuming a soy sauce product are known to have 0.16 ppm (common level of soy sauce products recorded in the Philippines) of 3-MCPD has to consume 700 milliliters of this product on a daily basis for years before he will be at risk of probably developing cancer.
The FDA guarantees that the process is passed by the producer of soy sauce equally here and abroad. Local manufacturers and distributors of imported soy sauce are mandated to be licensed by the FDA to ensure observance to current GMP. A credential of analysis of 3-MCPD is also necessary before the FDA License to Operate as food manufacturer or distributors are issued. In addition, the FDA necessitates product registration of all imported soy sauce before they are permitted in the market. The Certificate of Product Registration is only issued to companies that observed with safety, purity and manufacturing qualifications of their product. Thus, all soy sauce products that are under the authority of the FDA have accepted safety evaluation, including safe level of 3-MCPD.
FDA is concerned with market retail performances that cooperates the safety of soy sauce based on the “tingi-tingi” practice which entails opening the product package and repacking in plastic bags under unclean conditions. The FDA discourages the retailing of unlabelled soy sauce products. FDA has associated up eight LGUs to discover possible resolutions to these problems. The public is enjoined to purchase soy sauce products in their original bottle as accepted by the FDA.
FDA is also disturbed that there are imported products in the alternative markets that are not registered and is involving with the Bureau of Customs to develop controls and avoid such products from entering the country.  FDA is encouraging all distributors and traders to record imported products that they may want to market in the Philippines.

You Might Also Like